37
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Recent Advances in Clostridium difficile and its Toxins: Report of a Workshop held at Tours, France, 4 May, 1995

&
Pages 181-197 | Published online: 11 Jul 2009

References

  • Bordello S P. Pathogenesis of Clostridium difficile infection of the gut. Journal of Medical Microbiology 1990; 33: 207–215
  • Borriello S P., Davies H A., Kamiya S, Reed P J., Seddon S. Virulence factors of Clostridium difficile. Reviews of Infectious Diseases 1990; 12: S185–S190, (Suppl. 2)
  • Green G A., Schue V, Monteil H. Cloning and characterization of the cytotoxin L-encoding gene of Clostridium sordellii: homology with Clostridium difficile cytotoxin B. Gene 1995, (in press)
  • Schue V, Green G A., Girardot R, Monteil H. Clostridium sordellii cytotoxin induces phosphorylation of an 80 000 mol wt protein in McCoy cultured cells. Toxicon 1994; 32: 1581–1592
  • Schue V, Green G A., Girardot R, Monteil H. Hyperphosphorylation of calnexin, a chaperone protein, induced by Clostridium difficile cytotoxin. BBRC 1994; 203: 22–28
  • Florin I. Isolation of a fibroblast mutant resistant to Clostridium difficile toxins A and B. Microbial Pathogenesis 1991; 11: 337–346
  • Just I, Fritz G, Aktories K, Giry M, Popoff M R., Boquet P, Hegenbarth S, Von Eichel-Streiber C. Clostridium difficile toxin B acts on the GTP-binding protein. Rho. Journal of Biological Chemistry 1994; 269: 10 706–10 712
  • Augeron C, Laboisse C L. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Research 1984; 44: 3961–3969
  • Bou-Hanna C, Jarry A, Nguyen Van P, Laboisse C L. Clostridium difficile toxin-A polarized entry and modulation of exocytosis in a human colonic mucus-secreting cell line (CI. 16E). Gastroenterology 1994; 106: A655
  • Fogh J, Trempe G. New human tumor cell lines. Human Tumor Cells in vitro, J. Fogh. Plenum Press, New York 1975; 115–141
  • Hecht G, Pothoulakis C, LaMont J T., Madara J L. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. Journal of Clinical Investigation 1988; 82: 1516–1524
  • Hecht G, Koutsouris A, Pothoulakis C, LaMont J T., Madara J L. Clostridium difficile toxin-B disrupts the barrier function of T84 monolayers. Gastroenterology 1992; 102: 416–423
  • Laboisse C L. Differentiation of colon cells in culture. The Cell and Molecular Biology of Colon Cancer, LH Augenlicht. CRC Press, Boca Raton 1989; 27–43
  • Kelly C P. Immune response to Clostridium difficile infection. European Journal of Gastroenterology and Hepatology, (in press)
  • Kelly C P., Pothoulakis C, LaMont J T. Clostridium difficile colitis. New England Journal of Medicine 1994; 330: 257–262
  • Kelly C P., Pothoulakis C, Orellana J, LaMont J T. Human colonic aspirates containing IgA antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding. Gastroenterology 1992; 102: 35–40
  • Kelly C P., Vavva F, Castagliuolo I, Bostwick E, Keates S, LaMont J T., Pothoulakis C. Bovine immunoglobulin concentrate, a novel approach to Clostridium difficile colitis. The American Journal of Gastroenterology 1995, (abstract in press)
  • Leung D Y., Kelly C P., Boguniewicz M, Pothoulakis C, LaMont J T., Flores A. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. Journal of Pediatrics 1991; 118: 633–637